Related Experiment Video
Updated: Jul 5, 2026
08:11
Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
[Physiological properties and possible correction of adenosine triphosphate-sensitive potassium channel function]
Fiziolohichnyi Zhurnal (Kiev, Ukraine : 1994)
|April 18, 2008
Summary
ATP-sensitive potassium channels (KATP) link cell metabolism and excitability. Their activation impacts smooth muscle, pancreatic beta-cells, and cardiac ischemia, offering therapeutic potential for diabetes and cardiovascular conditions.
Area of Science:
- Physiology
- Molecular Biology
- Pharmacology
Context:
- ATP-sensitive potassium channels (KATP) are crucial for linking cellular metabolism and excitability in various tissues.
- These channels play significant roles in smooth muscle vasodilation and insulin secretion from pancreatic beta-cells.
Purpose:
- To review recent advancements in understanding the molecular mechanisms governing KATP channel activity.
- To explore the physiological and pathological roles of KATP channels.
- To identify unresolved questions in KATP channel research.
Summary:
- KATP channel activation leads to vasodilation in smooth muscle and influences insulin secretion in pancreatic beta-cells.
- Drugs like sulfonylureas target KATP channels for type 2 diabetes treatment by inhibiting KATP current, promoting insulin release.
- Specific KATP activators, such as diazoxide and pinacidil, reduce insulin secretion and lower blood pressure, offering therapeutic benefits by limiting intracellular calcium influx.
Impact:
- KATP channel activation in cardiac ischemia reduces action potential duration, limits calcium influx, and provides cardioprotective effects.
- Understanding KATP channel function offers insights into treating metabolic and cardiovascular diseases.
- Recent progress has significantly advanced our knowledge of KATP channel regulation and its implications in health and disease.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:21G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...